Pfizer Stock Poised for Turnaround on GLP-1 Hopes
$27.89 -0.16 (-0.57%) (As of 02:28 PM ET) 52-Week Range $25.20 ▼ $37.80 Dividend Yield 6.02% Price Target $35.54 Pharmaceutical giant Pfizer Inc. NYSE: PFE has been trying to enter the weight-loss treatment trend dominated by GLP-1 drug makers like Ozempic and Wegovy makers Novo Nordisk A/S NYSE: NVO and Mounjaro and Zepbound makers Eli Lilly…